Here, we describe a patient with HER2-positive metastatic breast cancer with brain metastases who achieved long-term systemic and intracranial stability following CNS-directed local therapy and subsequent T-DM1 treatment. The gene discussed is ERBB2; the disease is breast carcinoma.